N-Morpholinyllysergamide tartrate(119248-45-2)
- Name: N-Morpholinyllysergamide tartrate
- Synonyms:N-Morpholinyllysergamide tartrate;R5MY5P0GJ9;Morpholine, 4-lysergoyl-, tartrate;d-Lysergic acid morpholide, tartaric acid salt;UNII-R5MY5P0GJ9;63938-26-1;Ergoline-8-beta-carboxylic acid, 9,10-didehydro-6-methyl-, morpholide, tartaric acid salt;119248-45-2;Morpholine, 4-((8beta)-(9,10-didehydro-6-methylergolin-8-yl)carbonyl)-, (2R,3R)-2,3-dihydroxybutanedioate;DTXSID20981221;LS-64388;Q27287823;2,3-Dihydroxybutanedioic acid--(6-methyl-9,10-didehydroergolin-8-yl)(morpholin-4-yl)methanone (1/1);MORPHOLINE, 4-((8.BETA.)-(9,10-DIDEHYDRO-6-METHYLERGOLIN-8-YL)CARBONYL)-, (2R,3R)-2,3-DIHYDROXYBUTANEDIOATE;Morpholine, 4-[(8.beta.)-(9,10-didehydro-6-methylergolin-8-yl)carbonyl]-, [R-(R*,R*)]-2,3-dihydroxybutanedioate
- Molecular Formula:C24H29N3O8
- Molecular Weight:487.5
- CAS Registry Number:119248-45-2
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 59180-14-2/Glycinamide, N-(4-chloro-2-(2-chlorobenzoyl)phenyl)-N-methyl-D-phenylalanyl-, monohydrobromide
- 55156-24-6/Azotomycin sodium
- 55212-36-7/4-[(2-Methylphenyl)methyl]-1-piperazinecarboximidamide
- 55300-31-7/2-[4-(3-Chlorophenyl)-1-piperazinyl]ethyl 2-[(7-chloro-4-quinolinyl)amino]benzoate
- 55875-51-9/alpha,2-Dimethyl-4-dimethylaminophenethylamine dihydrochloride
- 33286-33-8/Metoprolol hydrochloride
- 765843-06-9/Dbh4buh2UR
- 532414-36-1/N-(2-Hydroxy-5-((1RS)-1-hydroxy-2-(((1SR)-2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)formamide
- 59695-62-4/endo-(+-)-3-(7-Methyl-6-(2-propenyl)-6-azabicyclo(3.2.1)oct-1-yl)phenol hydrochloride
- 69716-06-9/3,5,6,7-Tetrahydro-s-indacen-1(2H)-one O-[2-(dimethylamino)ethyl]oxime
- 63121-20-0/Neomycin C hydrochloride
- 34888-32-9/Norepinephrine bitartrate
- 60218-35-1/Pirandamine hydrochloride
- 60218-36-2/pirandamine
- 62099-44-9/pirandamine hydrochloride
- 736870-60-3/Pirdonium
- 5301-32-6/(trans)-5-Methyl-3-(N-methyl-N-phenethylamino)-1-phenyl-2-pyrrolidinone picrolonate
- 63903-75-3/Xenagol
- 63907-08-4/5-Norbornene-2,3-dicarboximide, 5-(alpha-hydroxy-alpha-2-pyridylbenzyl)-7-(alpha-2-pyridylbenzylidene)-, hydrochloride
- 119248-45-2/N-Morpholinyllysergamide tartrate
- 748715-80-2/4-[[5-(4-Fluorophenyl)-2-oxazolyl]methyl]-1-piperazineethanol
- 63503-44-6/2-Amino-1,3,4-thiadiazole methiodide
- 65446-83-5/N,N-Dipropyl-gamma-hydroxy-1-piperidinepentanamide monohydrochloride
- 4227-71-8/N-(1-Hydroxypropan-2-yl)-1,6-dimethyl-9,10-didehydroergoline-8-carboximidic acid
- 71549-04-7/Butanoic acid, 2-(4-((2,4-dichlorophenyl)methyl)phenoxy)-2-methyl-, ethyl ester, (+-)-
- 100333-41-3/N,N'-Dithiobis(ethylene)bis(2,1,3-benzothia(S(sup IV))diazole-4-methylamine)
- 72336-12-0/N-(9H-Fluorene-9-yl)-2-(diethylamino)acetamide
- 100991-82-0/Hellebrigenin glucoside
- 74246-72-3/Spiro(naphthalene-1(2H),3'-pyrrolidine)-2',5'-dione, 3,4-dihydro-1'-(2-(dimethylamino)ethyl)-, hydrochloride, (+-)-
- 74246-81-4/Spiro(naphthalene-1(2H),3'-pyrrolidine)-2',5'-dione, 3,4-dihydro-1'-(3-(methylpropylamino)propyl)-, hydrochloride, (+-)-